Wang Y, Roach P J
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis 46202-5122.
J Biol Chem. 1993 Nov 15;268(32):23876-80.
Rabbit skeletal muscle glycogen synthase, a rate-limiting enzyme for glycogen biosynthesis, is regulated by multisite phosphorylation. The protein kinase glycogen synthase kinase 3 (GSK-3) phosphorylates 4 Ser residues (Ser-640, Ser-644, Ser-648, and Ser-652; also known as sites 3a, 3b, 3c, and 4, respectively) at the COOH terminus of the subunit. Phosphorylation of these sites by GSK-3 is sequential, from COOH- to NH2-terminal, and is wholly dependent on prior phosphorylation by casein kinase II at Ser-656 (site 5). Expression in Escherichia coli was used to generate mutant forms of glycogen synthase, S640A, S644A, and S648A, in which site 3a, site 3b, or site 3c was changed to Ala, respectively. The purified enzymes had -/+ glucose-6-P activity ratios in the range of 0.8-0.9. Phosphorylation by casein kinase II and GSK-3 gave results consistent with the model of obligate sequential action of GSK-3. Phosphorylation at site 5, sites 4 + 5, or sites 3c + 4 + 5 had no measurable effect on activity. When sites 3b + 3c + 4 + 5 were phosphorylated, modest inactivation resulted. Additional phosphorylation at site 3a, however, was potently inactivating, reducing the -/+ glucose-6-P activity ratio to 0.1 and increasing the glucose-6-P concentration needed for half-maximal activation by an order of magnitude. Introduction of each additional phosphate, in the order site 4, 3c, 3b, and 3a, caused an incremental reduction in the mobility of the subunit when analyzed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. The results of this study demonstrate that GSK-3 phosphorylation of site 3a (Ser-640), and to a lesser extent, site 3b, correlates with inactivation of glycogen synthase by GSK-3. Evidence is also presented for an allosteric mechanism of inactivation whereby modification of one subunit influences the activity state of adjacent subunits.
兔骨骼肌糖原合酶是糖原生物合成的限速酶,受多位点磷酸化调节。蛋白激酶糖原合酶激酶3(GSK-3)使该亚基COOH末端的4个丝氨酸残基(Ser-640、Ser-644、Ser-648和Ser-652;也分别称为位点3a、3b、3c和4)发生磷酸化。GSK-3对这些位点的磷酸化是从COOH端到NH2端依次进行的,并且完全依赖于酪蛋白激酶II先对Ser-656(位点5)进行磷酸化。利用大肠杆菌中的表达来生成糖原合酶的突变形式S640A、S644A和S648A,其中位点3a、位点3b或位点3c分别被替换为丙氨酸。纯化后的酶的-/+葡萄糖-6-磷酸活性比在0.8 - 0.9范围内。酪蛋白激酶II和GSK-3的磷酸化结果与GSK-3的专一性顺序作用模型一致。在位点5、位点4 + 5或位点3c + 4 + 5处的磷酸化对活性没有可测量的影响。当位点3b + 3c + 4 + 5被磷酸化时,会导致适度的失活。然而,在位点3a处的额外磷酸化具有很强的失活作用,将-/+葡萄糖-6-磷酸活性比降低至0.1,并使半最大激活所需的葡萄糖-6-磷酸浓度增加一个数量级。当在十二烷基硫酸钠存在的情况下通过聚丙烯酰胺凝胶电泳进行分析时,按位点4、3c、3b和3a的顺序引入每个额外的磷酸会导致亚基迁移率逐渐降低。本研究结果表明,GSK-3对位点3a(Ser-640)以及程度较小的位点3b的磷酸化与GSK-3使糖原合酶失活相关。还提出了一种变构失活机制的证据,即一个亚基的修饰会影响相邻亚基的活性状态。